Kabra Drugs Ord Shs (524322) Stock Price & News

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	197.64M	304.20M	354.06M	462.17M
Cost of goods sold	165.24M	273.24M	331.18M	430.02M
Cost of revenue	165.24M	273.24M	331.18M	430.02M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.57M	3.85M	4.49M	2.37M
Operating expense	12.14M	6.77M	9.59M	4.46M
Total operating expenses	177.38M	280.01M	340.77M	434.48M
Operating income	20.26M	24.19M	13.29M	27.69M
Other non operating income	1.79M	1.84M	-3.79M	765.00K
EBT including unusual items	22.05M	26.01M	14.15M	28.40M
EBT excluding unusual items	22.05M	26.01M	14.15M	28.40M
Income tax expense	3.68M	341.00K	3.58M	7.17M
Effective tax rate	16.70%	1.31%	25.34%	25.25%
Other operating expenses	8.45M	2.79M	4.67M	1.88M
Net income	18.37M	25.66M	10.56M	21.23M
Net profit margin	9.29%	8.44%	2.98%	4.59%
Earnings per share	-	-	-	-
Interest and investment income	-	-	4.93M	-
Interest expense	-	-25.00K	-275.00K	-53.00K
Net interest expenses	-	-25.00K	4.65M	-53.00K
Depreciation and amortization charges	120.00K	127.00K	430.00K	206.00K
EBITDA	20.34M	24.21M	13.38M	27.78M
Gain or loss from assets sale	-	-	-	-

Finance